Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-31 07:22 am Sale | 2026-06-30 | 13G | PHARVARIS N V REGISTERED PHVS | LSP V Cooperatieve U.A. | 3,424,609 4.900% | -132,196 (-3.72%) | Filing History |
| 2024-02-08 4:16 pm Sale | 2023-12-31 | 13G | PHARVARIS N V REGISTERED PHVS | LSP V Cooperatieve U.A. | 3,556,805 6.800% | -50,761 (-1.41%) | Filing History |
| 2023-02-24 07:00 am Unchanged | 2023-02-23 | 13D | IMMUNIC INC IMUX | LSP V Cooperatieve U.A. | 216,278 4.900% | 0 (Unchanged) | Filing History |
| 2023-02-10 07:06 am Sale | 2022-12-31 | 13G | ORPHAZYME A/S ADR ORPHY | LSP V Cooperatieve U.A. | 2,426,711 6.900% | -169,450 (-6.53%) | Filing History |
| 2022-02-03 4:18 pm Purchase | 2021-12-31 | 13G | PHARVARIS N V REGISTERED PHVS | LSP V Cooperatieve U.A. | 3,607,566 10.900% | 3,607,566 (New Position) | Filing History |
| 2022-02-03 4:16 pm Sale | 2021-12-31 | 13G | ORPHAZYME A/S ADR ORPHY | LSP V Cooperatieve U.A. | 2,596,161 7.000% | -114,668 (-4.23%) | Filing History |
| 2022-02-03 4:16 pm Unchanged | 3021-12-31 | 13D | ELOXX PHARMACEUTICALS INC ELOX | LSP V Cooperatieve U.A. | 6,713 3.400% | 0 (Unchanged) | Filing History |